Termination of Registration of a Class of Security Under Section 12(b) (15-12b)
February 23 2018 - 8:27AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION
OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number:
001-33609
SUCAMPO PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
805 King Farm
Blvd, Suite 550
Rockville, Maryland 20850
(301)
961-3400
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Class A Common Stock, par value $0.01 per share
(Title of each class of securities covered by this Form)
None
(Titles of all
other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an
X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
|
|
|
|
Rule 12g-4(a)(1)
|
|
☒
|
|
Rule 12g-4(a)(2)
|
|
☐
|
|
Rule 12h-3(b)(1)(i)
|
|
☒
|
|
Rule 12h-3(b)(1)(ii)
|
|
☐
|
|
Rule 15d-6
|
|
☐
|
Approximate number of holders of record as of the certification or notice date:
Common Stock, par value $0.01 per share: 1
Pursuant to the requirements of the Securities Exchange Act of 1934, Sucampo Pharmaceuticals,
Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
|
|
|
|
|
|
|
|
|
Date: February 23, 2018
|
|
|
|
SUCAMPO PHARMACEUTICALS, INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Kathleen A. Schaefer
|
|
|
|
|
|
|
|
Name: Kathleen A. Schaefer
|
|
|
|
|
|
|
|
Title: President
|
Sucampo Pharmaceuticals, Inc. (delisted) (NASDAQ:SCMP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sucampo Pharmaceuticals, Inc. (delisted) (NASDAQ:SCMP)
Historical Stock Chart
From Apr 2023 to Apr 2024
